US FDA Panel Votes 'No' On Barricade Implant To Stop Reherniation
Executive Summary
A US FDA Orthopedics Advisory Panel voted 8-5 that the benefits do not outweigh the risks of implanting Intrinsic Therapeutics Inc.' Barricade prosthesis based on safety concerns, in particular a tendency for the device to break and separate into the lumbar column post implantation. Also, some panel members were not convinced that the device would improve patient function or allow people to return to their jobs.
You may also be interested in...
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.
US Medicare Agency Makes It Easier For Texas Suppliers To Replace DME Lost To Winter Storms
Durable medical equipment suppliers get temporary HHS and CMS waivers to help Texas Medicare and Medicaid beneficiaries due to the state’s winter storm.